title: [Rapid and severe development of fetal hemolytic disease due to anti-Kell antibodies].
authors.affiliation: Centre de Transfusion de Liège, Croix Rouge de Belgique, CHR Citadelle.
authors.forename: M C
authors.initials: MC
authors.lastname: Frère
authors.forename: J P
authors.initials: JP
authors.lastname: Schaaps
authors.forename: H
authors.initials: H
authors.lastname: Thoumsin
authors.forename: M C
authors.initials: MC
authors.lastname: Retz
authors.forename: J
authors.initials: J
authors.lastname: Rif
authors.forename: J
authors.initials: J
authors.lastname: Rigo
authors.forename: T
authors.initials: T
authors.lastname: De Cortis
authors.forename: R
authors.initials: R
authors.lastname: Lambotte
authors.forename: J
authors.initials: J
authors.lastname: Senterre
authors.forename: D
authors.initials: D
authors.lastname: Sondag-Thull
mesh_terms: D000328:Adult; D001787:Blood Group Incompatibility / Q000150:complications* / Q000276:immunology; D002543:Cerebral Hemorrhage / Q000209:etiology; D004899:Erythroblastosis, Fetal / Q000150:complications / Q000209:etiology* / Q000628:therapy; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007518:Isoantibodies / Q000302:isolation & purification; D007626:Kell Blood-Group System / Q000276:immunology*
chemical_list: D007518:Isoantibodies; D007626:Kell Blood-Group System
vernacular_title: Maladie hémolytique foetale à développement rapide et sévère due à un anti-kell.